From: Role of urinary NAG enzyme in early detection of renal impairment in cystic fibrosis patients
Variables | N=40 (100%) | Median (Max–Min) |
---|---|---|
Age in years | 6 (12–2.5) | |
Age of presentation in months | 5 (72–1.0) | |
Duration of disease in months | 56 (12–108) | |
Duration of use of nephrotoxic drugs in months | 28 (6–54) | |
Residence | ||
Urban | 19 (47.5%) | |
Rural | 21 (52.5%) | |
Sex | ||
Male | 24 (60%) | |
Female | 16(40%) | |
Positive consanguinity | 18 (45%) | |
Positive family history with CF | 10 (25%) |